Experimental study on Omi/HtrA2 promoting prostate cancer cell (PC-3M) apoptosis

HU Xiao-yong,CHEN Xiao-chun,CHEN Zhao-hui,胡晓勇,陈晓春,陈朝晖,曾甫清,鲁功成
DOI: https://doi.org/10.3760/j.issn:1001-9030.2006.03.033
2006-01-01
Abstract:To study the expression of Omi/HtrA2 in human prostate cancer cell line (PC-3M), construct siRNA expressing vector and investigate the effect of Omi/HtrA2 on PC-3M apopto-sis. Methods The expression of Omi/HtrA2 in human prostate cancer cell line (PC-3M) was detected by means of RT-PCR and immunohistochemical techniques. According to the software of Invivogen company, Omi/HtrA2 specific siRNA sequence was designed, synthesized in vitro and cloned into the expression vector psiRNA-hH1neo. The constructed psiRNA-Omi/HtrA2 was transiently transfected into human prostate cancer cell line (PC-3M) and the inhibitory effect of psiRNA-Omi/HtrA2 on the expression of Omi/HtrA2 in PC-3M cells was detected using RT-PCR and Western Blot. The apoptosis of cancer cells was determined by flow cytometry and MTT techniques. Results The expression level of Omi/ HtrA2 was up-regulated in PC-3M cells. Enzyme digestion analysis and DNA sequencing confirmed that the Omi/HtrA2 specific siRNA expression vector was constructed successfully. The apoptosis of PC-3M and the expression of Omi/HtrA2 were down-regulated in prostate cancer cells after the transfection of psiRNA-Omi/HtrA2. Conclusion Omi/HtrA2 can result in the apoptosis of prostate cancer cells. Omi/ HtrA2 expression might be involved in prostate cancer development.
What problem does this paper attempt to address?